ICU Medical Analyst Price Targets - Benzinga

ICU Medical Inc

ICUINASDAQ

Trade with Public

Trade with Public

$164.03

-0.92-0.56%

近くで: Sep 28, 5:00 PM EST

$164.03

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

ICU Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for ICU Medical (ICUI).

Price Target Range — 12 Quarters

Analyst Consensus — 7 Analysts

1S.Buy

6Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$181Upside to Avg. PT+10.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$163→$195
Aug 7, 2026	BTIG	Sam Eiber	PT Raise	Buy	$170→$200
Aug 7, 2026	Needham	Mike Matson	PT Raise	Buy	$165→$187
Jul 21, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$164→$182
Jun 15, 2026	BTIG	Sam Eiber	Initiate	Buy	$170
May 27, 2026	Needham	Mike Matson	Upgrade	Hold→Buy	$165
Apr 27, 2026	Keybanc	Brett Fishbin	PT Cut	Overweight	$180→$164
Apr 17, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$178→$163
Feb 20, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$175→$180
Feb 20, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$172→$178
Nov 7, 2025	Keybanc	Brett Fishbin	PT Raise	Overweight	$173→$175
Nov 7, 2025	Piper Sandler	Jason Bednar	PT Raise	Overweight	$153→$172
Oct 21, 2025	Keybanc	Brett Fishbin	PT Cut	Overweight	$191→$173
Sep 10, 2025	Piper Sandler	Jason Bednar	PT Raise	Overweight	$145→$153
Aug 15, 2025	Piper Sandler	Jason Bednar	Initiate	Overweight	$145
Aug 8, 2025	Raymond James	Jayson Bedford	PT Cut	Strong Buy	$187→$180
May 9, 2025	Raymond James	Jayson Bedford	PT Cut	Strong Buy	$197→$187
Apr 21, 2025	Keybanc	Tim Rezvan	PT Cut	Overweight	$209→$191
Apr 8, 2025	Needham	Mike Matson	Maintained	Hold	—
Mar 12, 2025	Raymond James	Jayson Bedford	PT Cut	Outperform→Strong Buy	$205→$197

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $195

Piper Sandler analyst Jason Bednar maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $163 to $195.

Benzinga Newsdesk

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.

Avi Kapoor

PRO
BTIG Maintains Buy on ICU Medical, Raises Price Target to $200

BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.

Benzinga Newsdesk

PRO
Needham Maintains Buy on ICU Medical, Raises Price Target to $187

Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182

Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $164 to $182.

Benzinga Newsdesk

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.

Avi Kapoor